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Anthracycline antibiotics (ANT), such as daunorubicin, doxorubicin or epirubicin, belong 
amongst the most effective antineoplastic drugs. They are being used to treat leukemias as well 
as solid tumors. One of the limiting factors of these highly active substances is their 
cardiotoxicity. Supposedly, cardiotoxicity can originate in the following basis; either by the 
interaction with Fe ions which form reactive oxygen species (ROS) or directly caused by the 
inhibition of topoisomerase IIβ by ANTs in cardiomyocytes. Irreversible damage to heart 
muscle cells can lead to heart failure. Dexrazoxane (DEX) is the only drug clinically used for 
ANT-inducted cardiotoxicity prevention. DEX is a bisdioxopiperazine derivative, and its 
mechanism of action is not fully clear. There are two main hypotheses: 1. chelation of 
intracellular iron ions and reduction of ROS formation, 2. catalytic inhibition of topoisomerase 
IIβ. 
 
Figure 1: Structure of dexrazoxane and dexrazoxane analogues prepared in this thesis. 
The thesis aimed to prepare DEX analogues with a modified linker. Namely, the butane-2,3-
diyl analogue (JAS) and pentane-2,3-diyl analogue (EMD). The first key point in the synthesis 
of the desired analogues was the preparation of the corresponding diamines. The initial 
compounds were butane-2,3-diol and pentane-2,3-dione, reduced to pentane-2,3-diol. It was 
necessary to separate the diastereomers during the synthesis to obtain pure products and/or pure 
racemic mixtures. In the EMD synthesis, the separation of diastereomers took place during the 
purification of tetra(tert-butyl) ester of 2,3-diaminopentane-N,N,N',N'-tetracetic acid through 
the column chromatography. The JAS synthesis enabled the separation of racemate from meso-
form of butane-2,3-diamine dihydrochloride due to their different ability to crystallize from the 
reaction mixture. The critical point of the synthesis was the cyclization of bisdioxopiperazine 
cycles. Two alternative approaches were utilized. The first method was the cyclization of 
N,N,N',N'-tetraacetic acid in formamide at a high temperature. The second method used 
tetramethyl ester, which cyclized in dioxane using formamide and sodium hydride. Both 
cyclization reactions resulted in the final products in the yield 11–66 %.  
 
Figure 2: Scheme of synthesis bisdioxopiperavine derivatives 
The final compounds were tested for cardioprotective potential and their inhibitory activity to 
topoisomerase IIβ in vitro was examined. The results showed that the position of the 
substituents on the linker has an impact on their effectiveness. Furthermore, both substances 
proved to have cardioprotective activity, but it depended on the configuration on the chiral 
carbons. 
 
